FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Johnson & Johnson Stock AnalysisComprehensive stock analysis for Johnson & Johnson (JNJ) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisJNJ
JNJ
Johnson & Johnson
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
JNJ
Home🔹Stocks🔹Johnson & Johnson

Johnson & Johnson

JNJ•NYSE

Johnson & Johnson

JNJ•NYSE
Market cap
$642.79B
Sentiment

Your view on JNJ

Mkt Cap
$642.79B
Sentiment
Your view
JNJ
Johnson & Johnson
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
JNJ
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Johnson & Johnson

Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Joaquin Duato
Headquarters
One Johnson & Johnson Plaza, New Brunswick, NJ, US
Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Joaquin Duato
Headquarters
One Johnson & Johnson Plaza, New Brunswick, NJ, US
Description

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News